Expression and function of tumour necrosis factor-α-converting enzyme in the central nervous system

被引：22

作者：

Moro, MA ^{[1
]}

Hurtado, O ^{[1
]}

Cárdenas, A ^{[1
]}

Romera, C ^{[1
]}

Madrigal, JLM ^{[1
]}

Fernández-Tomé, P ^{[1
]}

Leza, JC ^{[1
]}

Lorenzo, P ^{[1
]}

Lizasoain, I ^{[1
]}

机构：

[1] Univ Complutense Madrid, Fac Med, Dept Farmacol, ES-28040 Madrid, Spain

来源：

NEUROSIGNALS | 2003年 / 12卷 / 02期

关键词：

metalloproteases; neuroinflammation; stroke; ischemic tolerance; neuroprotection;

D O I：

10.1159/000071814

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Tumour necrosis factor-alpha (TNF-alpha)-converting enzyme (TACE/ADAM17) is a membrane protein belonging to the ADAM (a disintegrin and a metalloprotease) family able to cleave various membrane proteins, including the transmembrane form of TNF-alpha at its physiological processing site. Being an ADAM, TACE may mediate not only proteolysis but also adhesive interactions; however, the role of the disintegrin domain of TACE has not been studied. In the central nervous system (CNS), little is known about the physiological role of TACE, but some important pathophysiological functions have been reported recently, with both neurotoxic and neuroprotective repercussions. This article discusses and reviews the main contributions to this field of investigation addressing the expression and function of TACE in the CNS. Copyright (C) 2003 S. Karger AG, Basel.

引用

页码：53 / 58

页数：6

共 50 条

[41] The Role of Tumor Necrosis Factor-α Converting Enzyme in Renal Transplant Rejection
Wang, Jun
Li, Zilong
Al-Lamki, Rafia
Wang, Juan
Zuo, Nan
Bradley, John R.
Wang, Lining
AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (04) : 362 - 368
[42] Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme
Reddy, P
Slack, JL
Davis, R
Cerretti, DP
Kozlosky, CJ
Blanton, RA
Shows, D
Peschon, JJ
Black, RA
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) : 14608 - 14614
[43] Domain organization of the human tumor necrosis factor-α converting enzyme (TACE)
Miller, AB
Moss, M
Mitchell, J
Clay, W
Carter, HL
Buckhart, W
Chen, WJ
Didsbury, J
Hoffman, C
Jin, C
Kost, T
Lambert, M
Leesnitzer, MA
McCauley, P
Moyer, M
Pahel, G
Su, JL
Becherer, JD
Milla, M
FASEB JOURNAL, 1997, 11 (09): : A1225 - A1225
[44] Natural inhibitors of tumour necrosis factor-α production, secretion and function
Habtemariam, S
PLANTA MEDICA, 2000, 66 (04) : 303 - 313
[45] Molecular Descriptors in Modelling the Tumour Necrosis Factor-α Converting Enzyme Inhibition Activity of Novel Tartrate-Based Analogues
Singh, P.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 75 (01) : 36 - 44
[46] Expression of tumour necrosis factor-α and its receptors in Hodgkin lymphoma
Nakayama, Shoko
Yokote, Taiji
Tsuji, Motomu
Akioka, Toshikazu
Miyoshi, Takuji
Hirata, Yuji
Hiraoka, Nobuya
Iwaki, Kazuki
Takayama, Ayami
Nishiwaki, Uta
Masuda, Yuki
Hanafusa, Toshiaki
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (04) : 574 - 577
[47] Expression of tumor necrosis factor α converting enzyme in endocrine cancers
Kirkegaard, Tove
Naresh, Anjali
Sabine, Vicky S.
Tovey, Sian M.
Edwards, Joanne
Dunne, Barbara
Cooke, Timothy G.
Jones, Frank E.
Bartlett, John M. S.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (05) : 735 - 743
[48] Characterization of the tumour necrosis factor α-converting enzyme, TACE/ADAM17
Cerretti, DP
BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 (02) : 219 - 223
[49] Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement
Minden, K
Aganna, E
McDermott, MF
Zink, A
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) : 1356 - 1357
[50] Design of selective and soluble inhibitors of tumor necrosis factor-α converting enzyme (TACE)
Rabinowitz, MH
Andrews, RC
Becherer, JD
Bickett, DM
Bubacz, DG
Conway, JG
Cowan, DJ
Gaul, M
Glennon, K
Lambert, MH
Leesnitzer, MA
McDougald, DL
Moss, ML
Musso, DL
Rizzolio, MC
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) : 4252 - 4267

← 1 2 3 4 5 →